Эпилепсия и эпилептический статус у взрослых и детей
 Скачать 1.94 Mb.
|
|
Biobehavioral Reviews. Elsevier Ltd, 2014. Vol. 43. P. 20–34. 173. Rayner G., Wrench J.M., Wilson S.J. Differential contributions of objective memory and mood to subjective memory complaints in refractory focal epilepsy // Epilepsy Behav. Epilepsy Behav, 2010. Vol. 19, № 3. P. 359–364. 174. Oyegbile T.O. et al. The nature and course of neuropsychological morbidity in chronic temporal lobe epilepsy // Neurology. Lippincott Williams and Wilkins, 2004. Vol. 62, № 10. P. 1736–1742. 175. Baker G.A., Taylor J., Aldenkamp A.P. Newly diagnosed epilepsy: Cognitive outcome after 12 months // Epilepsia. Epilepsia, 2011. Vol. 52, № 6. P. 1084–1091. 176. Butler C.R., Zeman A.Z. Recent insights into the impairment of memory in epilepsy: Transient epileptic amnesia, accelerated long-term forgetting and remote memory impairment // Brain. Oxford University Press, 2008. Vol. 131, № 9. P. 2243–2263 177. Neligan A., Shorvon S.D. Prognostic factors, morbidity and mortality in tonic-clonic status epilepticus: A review // Epilepsy Research. Epilepsy Res, 2011. Vol. 93, № 1. P. 1–10. 178. Helmstaedter C. Cognitive outcome of status epilepticus in adults // Epilepsia. Epilepsia, 2007. Vol. 48, № SUPPL. 8. P. 85–90. 217 179. Tinuper P. et al. Epileptic drop attacks in partial epilepsy: Clinical features, evolution, and prognosis // J. Neurol. Neurosurg. Psychiatry. BMJ Publishing Group, 1998. Vol. 64, № 2. P. 231–237. 180. Parra-Díaz P., García-Casares N. Memory assessment in patients with temporal lobe epilepsy to predict memory impairment after surgery: A systematic review // Neurologia. Spanish Society of Neurology, 2019. Vol. 34, № 9. P. 596–606. 181. Harvey D.J. et al. Relationship between presurgical memory performance on the Wechsler Memory Scale-III and memory change following temporal resection for treatment of intractable epilepsy // Epilepsy Behav. Epilepsy Behav, 2008. Vol. 13, № 2. P. 372–375. 182. Äikiä M. et al. Verbal Memory in Newly Diagnosed Patients and Patients with Chronic Left Temporal Lobe Epilepsy // Epilepsy Behav. Epilepsy Behav, 2001. Vol. 2, № 1. P. 20–27. 183. LoGalbo A. et al. Verbal memory outcome in patients with normal preoperative verbal memory and left mesial temporal sclerosis // Epilepsy Behav. Epilepsy Behav, 2005. Vol. 6, № 3. P. 337–341. 184. Baxendale S., Thompson P.J., Sander J.W. Neuropsychological outcomes in epilepsy surgery patients with unilateral hippocampal sclerosis and good preoperative memory function // Epilepsia. Epilepsia, 2013. Vol. 54, № 9. 185. Sherman E.M.S. et al. Neuropsychological outcomes after epilepsy surgery: Systematic review and pooled estimates // Epilepsia. Epilepsia, 2011. Vol. 52, № 5. P. 857–869. 186. Helmstaedter C. Cognitive outcomes of different surgical approaches in temporal lobe epilepsy // Epileptic Disorders. Epileptic Disord, 2013. Vol. 15, № 3. P. 221–239. 187. Bjellvi J. et al. Complications of epilepsy surgery in Sweden 1996-2010: A prospective, population-based study // J. Neurosurg. American Association of Neurological Surgeons, 2015. Vol. 122, № 3. P. 519–525. 188. Van Schooneveld M.M.J., Braun K.P.J. Cognitive outcome after epilepsy surgery in children // Brain and Development. Brain Dev, 2013. Vol. 35, № 8. P. 721–729. 189. Helmstaedter C. et al. Disentangling the relationship between epilepsy and its behavioral comorbidities - The need for prospective studies in new-onset epilepsies // Epilepsy and Behavior. Epilepsy Behav, 2014. Vol. 31. P. 43–47. 190. Gilliam F., Kanner A.M. Treatment of depressive disorders in epilepsy patients // Epilepsy and Behavior. Academic Press Inc., 2002. Vol. 3, № 5 SUPPL. 1. P. 2–9. 191. Wiebe S, Téllez-Zenteno JF, Shapiro M. An evidence-based approach to the first seizure. Epilepsia. 2008; 49 Suppl 1:50-7. doi: 10.1111/j.1528-1167.2008.01451.x. 218 192. Hirtz D. et al. Practice parameter: Evaluating a first nonfebrile seizure in children: Report of the Quality Standards Subcommittee of the American Academy of Neurology, the Child Neurology Society, and the American Epilepsy Society // Neurology. Lippincott Williams and Wilkins, 2000. Vol. 55, № 5. P. 616–623. 193. Fletcher E.M., Sharieff G. Necessity of lumbar puncture in patients presenting with new onset complex febrile seizures // West. J. Emerg. Med. West J Emerg Med, 2013. Vol. 14, № 3. P. 206–211. 194. Sadek A.A. et al. Diagnostic value of lumbar puncture among infants and children presenting with fever and convulsions // Electron. physician. Mehr Publishing Group, 2016. Vol. 8, № 4. P. 2255–2262. 195. Vezzani A, Fujinami RS, White HS, Preux PM, Blümcke I, Sander JW, Löscher W. Infections, inflammation and epilepsy. Acta Neuropathol. 2016 Feb;131(2):211-234. doi: 10.1007/s00401-015-1481-5. Epub 2015 Sep 30. PMID: 26423537; PMCID: PMC4867498 196. Scramstad C., Jackson A.C. Cerebrospinal Fluid Pleocytosis in Critical Care Patients with Seizures // Can. J. Neurol. Sci. Cambridge University Press, 2017. Vol. 44, № 4. P. 343–349. 197. Blinder T., Lewerenz J. Cerebrospinal fluid findings in patients with autoimmune encephalitis-a systematic analysis // Front. Neurol. Frontiers Media S.A., 2019. Vol. 10, № JUL. 198. Cabezudo-García P. et al. Efficacy of antiepileptic drugs in autoimmune epilepsy: A systematic review // Seizure. W.B. Saunders Ltd, 2018. Vol. 59. P. 72–76. 199. Dubey D. et al. Neurological autoantibody prevalence in epilepsy of unknown etiology // JAMA Neurol. American Medical Association, 2017. Vol. 74, № 4. P. 397–402. 200. Dubey D. et al. Predictive models in the diagnosis and treatment of autoimmune epilepsy // Epilepsia. Blackwell Publishing Inc., 2017. Vol. 58, № 7. P. 1181–1189. 201. Сарапулова А.А., Айвазян С.О., Осипова К.В. Аутоиммунные энцефалопатии. Описание двух клинических случаев //QuantumSatis. – 2017. – Т. 1. – №. 2. – С. 72-83. 202. Del Brutto O.H. et al. Revised diagnostic criteria for neurocysticercosis // Journal of the Neurological Sciences. Elsevier B.V., 2017. Vol. 372. P. 202–210. 203. Reddy D.S., Volkmer R. Neurocysticercosis as an infectious acquired epilepsy worldwide // Seizure. W.B. Saunders Ltd, 2017. Vol. 52. P. 176–181. 204. Cattaneo D. et al. Association of HIV Infection with Epilepsy and Other Comorbid Conditions // AIDS Behav. Springer, 2020. Vol. 24, № 4. P. 1051–1055. 205. Лекции по ВИЧ-инфекции / под ред. В. В. Покровского. - 2-е изд., перераб. и доп. - М. : ГЭОТАР-Медиа, 2018. - 848 с. : ил. - ISBN 978- 5-9704-4374-3] 219 206. Sadeghi M. et al. An updated meta-analysis of the association between Toxoplasma gondii infection and risk of epilepsy // Trans. R. Soc. Trop. Med. Hyg. Oxford University Press, 2019. Vol. 113, № 8. P. 453–462. 207. Smithers-Sheedy H. et al. Congenital Cytomegalovirus among Children with Cerebral Palsy // J. Pediatr. Mosby Inc., 2017. Vol. 181. P. 267-271.e1. 208. Armangue T. et al. Frequency, symptoms, risk factors, and outcomes of autoimmune encephalitis after herpes simplex encephalitis: a prospective observational study and retrospective analysis // Lancet Neurol. Lancet Publishing Group, 2018. Vol. 17, № 9. P. 760–772. 209. Komaroff A.L., Pellett P.E., Jacobson S. Human herpesviruses 6a and 6b in brain diseases: Association versus causation // Clin. Microbiol. Rev. American Society for Microbiology, 2021. Vol. 34, № 1. P. 1–36. 210. Иерусалимский А.П. Прогредиентные формы клещевого энцефалита. — Новосибирск, 2011. — 76 с. 211. Taba P., Schmutzhard E., Forsberg P., Lutsar I., Ljøstad U., Mygland Å., Levchenko I., Strle F., Steiner I. EAN consensus review on prevention, diagnosis and management of tick-borne encephalitis. EurJNeurol. 2017; 24(10): 1214-e61 212. Haahr R. et al. Risk of neurological disorders in patients with european lyme neuroborreliosis: A nationwide, population-based cohort study // Clin. Infect. Dis. Oxford University Press, 2020. Vol. 71, № 6. P. 1511–1516. 213. Lee V.L.L. et al. Treatment, therapy and management of metabolic epilepsy: A systematic review // International Journal of Molecular Sciences. MDPI AG, 2018. Vol. 19, № 3. 214. Tomson T., Dahl M.L., Kimland E. Therapeutic monitoring of antiepileptic drugs for epilepsy // Cochrane Database of Systematic Reviews. John Wiley and Sons Ltd, 2007. № 2. 215. Patsalos P.N., Spencer E.P., Berry D.J. Therapeutic drug monitoring of antiepileptic drugs in epilepsy: A 2018 update // Therapeutic Drug Monitoring. Lippincott Williams and Wilkins, 2018. Vol. 40, № 5. P. 526–548. 216. Schoretsanitis G. et al. TDM in psychiatry and neurology: A comprehensive summary of the consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology, update 2017; a tool for clinicians* // World Journal of Biological Psychiatry. Taylor and Francis Ltd, 2018. Vol. 19, № 3. P. 162–174. 217. Johannessen Landmark C., Johannessen S.I., Patsalos P.N. Therapeutic drug monitoring of antiepileptic drugs: current status and future prospects // Expert Opinion on Drug Metabolism and Toxicology. TaylorandFrancisLtd, 2020. Vol. 16, № 3. P. 227–238. 220 218. Якунина А.В., Повереннова И.Е. Роль лечебного мониторинга лекарственных средств при применении противоэпилептических препаратов. Эпилепсия и пароксизмальные состояния . 2016; 8 (3): 66-73. (В рус.) Https://doi.org/10.17749/2077- 8333.2016.8.3.066-073]. 219. Беляев О. В, Самыгин Д. Рекомендации экспертного совета по нейрофизиологии Российской противоэпилептической лиги по проведению рутинной ЭЭГ // Эпилепсия и пароксизмальные состояния. 2017. Vol. 8, № 4. P. 99–108. 220. Синкин М.В. et al. Русскоязычный словарь терминов, используемых в клинической электроэнцефалографии // Нервные болезни. Общество с ограниченной ответственностью «Издательское предприятие «Атмосфера», 2021. № 1. P. 83–88. 221. Hasan TF, Tatum WO. When should we obtain a routine EEG while managing people with epilepsy?. Epilepsy Behav Rep. 2021;16:100454. Published 2021 May 3. doi:10.1016/j.ebr.2021.100454 222. Glick T.H. The sleep-deprived electroencephalogram: Evidence and practice // Arch. Neurol. Arch Neurol, 2002. Vol. 59, № 8. P. 1235–1239. 223. King M.A. et al. Epileptology of the first-seizure presentation: A clinical, electroencephalographic, and magnetic resonance imaging study of 300 consecutive patients // Lancet. Elsevier B.V., 1998. Vol. 352, № 9133. P. 1007–1011. 224. MARSAN C.A., ZIVIN L.S. Factors Related to the Occurrence of Typical Paroxysmal Abnormalities in the EEG Records of Epileptic Patients MARSAN, C. A., & ZIVIN, L. S. (1970). Factors Related to the Occurrence of Typical Paroxysmal Abnormalities in the EEG Records of Epileptic Patie // Epilepsia. Epilepsia, 1970. Vol. 11, № 4. P. 361–381. 225. Baldin E. et al. Yield of epileptiform electroencephalogram abnormalities in incident unprovoked seizures: A population-based study // Epilepsia. Blackwell Publishing Inc., 2014. Vol. 55, № 9. P. 1389–1398. 226. Salinsky M., Kanter R., Dasheiff R.M. Effectiveness of Multiple EEGs in Supporting the Diagnosis of Epilepsy: An Operational Curve // Epilepsia. Epilepsia, 1987. Vol. 28, № 4. P. 331–334. 227. Koutroumanidis M. et al. The role of EEG in the diagnosis and classification of the epilepsy syndromes: a tool for clinical practice by the ILAE Neurophysiology Task Force (Part 1) // Epileptic Disord. Wiley Blackwell, 2017. Vol. 19, № 3. P. 233–298. 228. Burkholder D.B. et al. Routine vs extended outpatient EEG for the detection of interictal epileptiform discharges // Neurology. Lippincott Williams and Wilkins, 2016. Vol. 86, № 16. P. 1524–1530. 221 229. Loddenkemper T., Fernández I.S., Peters J.M. Continuous spike and waves during sleep and electrical status epilepticus in sleep // J. Clin. Neurophysiol. J Clin Neurophysiol, 2011. Vol. 28, № 2. P. 154–164. 230. ShethR D. Electroencephalogram in developmental delay: specific electroclinical syndromes SeminPediatr Neurol. 1998 Mar;5(1):45-51. 231. Beghi E. et al. Withdrawal of antiepileptic drugs: Guidelines of the Italian League Against Epilepsy // Epilepsia. Epilepsia, 2013. Vol. 54, № SUPPL.7. P. 2–12. 232. Rosenow F., Karl Martin Klein &Hajo M Hamer (2015) Non-invasive EEG evaluation in epilepsy diagnosis, Expert Review of Neurotherapeutics, 15:4, 425-444, DOI: 10.1586/14737175.2015.1025382 233. Baumgartner C. et al. Presurgical epilepsy evaluation and epilepsy surgery // F1000Research. F1000 Research Ltd, 2019. Vol. 8. 234. West S., Nolan S.J., Newton R. Surgery for epilepsy: A systematic review of current evidence // Epileptic Disord. John Libbey Eurotext, 2016. Vol. 18, № 2. P. 113–121. 235. Seeck M. et al. The standardized EEG electrode array of the IFCN // Clin. Neurophysiol. Elsevier Ireland Ltd, 2017. Vol. 128, № 10. P. 2070–2077. 236. Usman S.M. et al. Using scalp EEG and intracranial EEG signals for predicting epileptic seizures: Review of available methodologies // Seizure. W.B. Saunders Ltd, 2019. Vol. 71. P. 258–269. 237. Климчук О.В. et al. Стандарты выполнения магнитно-резонансной томографии головного мозга для диагностики эпилепсии. Государственное бюджетное учреждение здравоохранения города Москвы" Научно …, 2016. P. 15. 238. Авакян Г.Н. et al. Рекомендации Российской Противоэпилептической Лиги (РПЭЛ) по использованию магнитно-резонансной томографии в диагностике эпилепсии // Эпилепсия и пароксизмальные состояния. Общество с ограниченной ответственностью «Ирбис», 2019. Vol. 11, № 3. P. 208–232. 239. Bernasconi A. et al. Recommendations for the use of structural magnetic resonance imaging in the care of patients with epilepsy: A consensus report from the International League Against Epilepsy Neuroimaging Task Force // Epilepsia. Blackwell Publishing Inc., 2019. Vol. 60, № 6. P. 1054–1068. 240. Duncan J.S. et al. Brain imaging in the assessment for epilepsy surgery // Lancet Neurol. Lancet Publishing Group, 2016. Vol. 15, № 4. P. 420–433. 241. Craven I. et al. 3.0 T MRI of 2000 consecutive patients with localisation-related epilepsy // Br. J. Radiol. Br J Radiol, 2012. Vol. 85, № 1017. P. 1236–1242. 222 242. Крылов В.В. et al. Хирургическое лечение больных с магнитно-резонансно- негативными фармакорезистентными формами эпилепсии // Неврологический журнал. ОАО «Издательство «Медицина», 2016. Vol. 21, № 4. P. 213–218. 243. Крылов В.В. et al. Клинические рекомендации по предоперационному обследованию и хирургическому лечению пациентов с фармакорезистентными формами эпилепсии // Неврологический журнал. 2015. Vol. 21, № 4. P. 213–218. 244. Крылов В.В. et al. Результаты хирургического лечения пациентов с фармакорезистентными формами эпилепсии // Нейрохирургия. 2017. № 1. P. 15–22. 245. Nakae S. et al. Association of preoperative seizures with tumor metabolites quantified by magnetic resonance spectroscopy in gliomas // Sci. Rep. Nature Research, 2021. Vol. 11, № 1. 246. Шалькевич Л.В., Кудлач А.И. Электроэнцефалографические и нейровизуализационные предикторы развития эпилепсии после однократного неспровоцированного приступа у детей // Неврология и нейрохирургия. Восточная Европа. Издательское частное унитарное предприятие" Профессиональные издания", 2016. Vol. 6, № 2. P. 189–196. 248. Abdelgawad E.A. et al. Magnetic resonance imaging (MRI) volumetry in children with nonlesional epilepsy, does it help? // Egypt. J. Radiol. Nucl. Med. Springer Open, 2021. Vol. 52, № 35. P. 1–11. 249. Bernasconi N., Wang I. Emerging Trends in Neuroimaging of Epilepsy // Epilepsy Curr. SAGE Publications Ltd, 2021. Vol. 21, № 2. P. 79–82. 250. Tranvinh E. et al. Imaging evaluation of the adult presenting with new-onset seizure // Am. J. Roentgenol. American Roentgen Ray Society, 2019. Vol. 212, № 1. P. 15–25. 251. Евстигнеев В.В., Сакович Р.А., Кистень О.В. Результаты первого опыта использования позитронно-эмиссионной томографии в Республике Беларусь для диагностики эпилепсии // Международный неврологический журнал. ФЛП «Заславский Александр Юрьевич», 2017. Vol. 3, № 89. P. 110–116. 252. Tang Y. Et al. FDG-PET Profiles of Extratemporal Metabolism as a Predictor of Surgical Failure in Temporal Lobe Epilepsy // Front. Med. Frontiers Media S.A., 2020. Vol. 7. 253. Chassoux F. et al. 18F-FDG-PET patterns of surgical success and failure in mesial temporal lobe epilepsy // Neurology. Lippincott Williams and Wilkins, 2017. Vol. 88, № 11. P. 1045–1053. 254. Stefanski A. et al. Clinical sequencing yield in epilepsy, autism spectrum disorder, and intellectual disability: A systematic review and meta-analysis // Epilepsia. Blackwell Publishing Inc., 2021. Vol. 62, № 1. P. 143–151. 223 255. Аношкин К.И., Карандашева К.О., Танас А.С., Бесонова Л.А., Демина Н.А., Петухова М.С., Анисимова И.В., Залетаев Д.В., Стрельников В.В. Медицинская технология комплексной ДНК-диагностики туберозного склероза. Медицинская генетика, 2018, Том 17 №8, стр. 32-37 256. Ritter D.M., Holland K. Genetic Testing in Epilepsy // Semin. Neurol. Thieme Medical Publishers, Inc., 2020. Vol. 40, № 6. P. 730–738. 257. Anney R.J.L. et al. Genetic determinants of common epilepsies: A meta-analysis of genome-wide association studies // Lancet Neurol. Lancet Publishing Group, 2014. Vol. 13, № 9. P. 893–903. 258. Singh R. et al. Chromosomal abnormalities and epilepsy: A review for clinicians and gene hunters // Epilepsia. Epilepsia, 2002. Vol. 43, № 2. P. 127–140. 259. Coppola A. et al. Diagnostic implications of genetic copy number variation in epilepsy plus // Epilepsia. Blackwell Publishing Inc., 2019. Vol. 60, № 4. P. 689–706. 260. Berkovic S.F. et al. The Epilepsy Genetics Initiative: Systematic reanalysis of diagnostic exomes increases yield // Epilepsia. Blackwell Publishing Inc., 2019. Vol. 60, № 5. P. 797–806. 261. Bonello D., Camilleri F., Calleja-AgiusJ. Angelman Syndrome: Identification and Management Neonatal Netw. 2017 May 1;36(3):142-151. 262. Байдакова Г.В., Иванова Т.А., Захарова Е.Ю., Кокорина О.С. Роль тандемной масс-спектрометрии в диагностике наследственных болезней обмена веществ // РЖДГиО. 2018. №3. 263. Campistol J. Epilepsy in Inborn Errors of Metabolism With Therapeutic Options // Semin. Pediatr. Neurol. W.B. Saunders, 2016. Vol. 23, № 4. P. 321–331. 264. van Karnebeek CD, Stockler S. Treatable inborn errors of metabolism causing intellectual disability: a systematic literature review. Mol Genet Metab. 2012 Mar;105(3):368- 81. doi: 10.1016/j.ymgme.2011.11.191. Epub 2011 Nov 30 265. Wilmshurst J.M. et al. Summary of recommendations for the management of infantile seizures: Task Force Report for the ILAE Commission of Pediatrics // Epilepsia. Blackwell Publishing Inc., 2015. Vol. 56, № 8. P. 1185–1197. 266. Gillis L., Kaye E. Diagnosis and management of mitochondrial diseases // Pediatric Clinics of North America. Pediatr Clin North Am, 2002. Vol. 49, № 1. P. 203–219. 267. Mulley GC, Mefford H.C. Epilepsy and the new cytogenetics. Epilepsia2011 Mar;52(3):423-32. 268. Fraser L.K. et al. Rising national prevalence of life-limiting conditions in children in England // Pediatrics. Pediatrics, 2012. Vol. 129, № 4. 224 269. Hain R. et al. Paediatric palliative care: Development and pilot study of a “Directory” of life-limiting conditions // BMC Palliat. Care. BMC Palliat Care, 2013. Vol. 12, № 1. 270. Вишняков Н.И. et al. Медико-социальные проблемы хосписов в педиатрической практике Санкт-Петербурга // Педиатр. Общество с ограниченной ответственностью «Эко-Вектор», 2014. Vol. 5, № 1. 271. Dallas J., Englot D.J., Naftel R.P. Neurosurgical approaches to pediatric epilepsy: Indications, techniques, and outcomes of common surgical procedures // Seizure. W.B. Saunders Ltd, 2020. Vol. 77. P. 76–85. 272. Лебедев К.Э., Маматханов М.Р. Показания и общие принципы хирургического лечения эпилепсии (обзор) // Нейрохирургия и неврология детского возраста. Федеральное государственное учреждение" Российский научно- исследовательский …, 2016. № 2. P. 66–78. 273. Макнамара-Гуджер К. и Фойдтнер К. Глава 1. История и эпидемиология. С. 5. Паллиативная помощь детям. Под редакцией Э. Голдман, Р. Хейна и С. Либена. Пер с англ. – М.: Практика, 2017. – 672 с. 274. Mattson R.H. et al. Comparison of Carbamazepine, Phenobarbital, Phenytoin, and Primidone in Partial and Secondarily Generalized Tonic–Clonic Seizures // N. Engl. J. Med. New England Journal of Medicine (NEJM/MMS), 1985. Vol. 313, № 3. P. 145–151. 275. Nevitt S.J. et al. Antiepileptic drug monotherapy for epilepsy: a network meta- analysis of individual participant data // Cochrane Database Syst. Rev. Wiley, 2017. Vol. 12, № 12. 276. Lattanzi S. et al. Antiepileptic monotherapy in newly diagnosed focal epilepsy. A network meta-analysis // Acta Neurologica Scandinavica. Blackwell Publishing Ltd, 2019. Vol. 139, № 1. P. 33–41. 277. Campos M.S. de A. et al. Efficacy and Tolerability of Antiepileptic Drugs in Patients with Focal Epilepsy: Systematic Review and Network Meta-analyses // Pharmacotherapy. Pharmacotherapy Publications Inc., 2016. Vol. 36, № 12. P. 1255–1271. 278. Baulac M. et al. Efficacy, safety, and tolerability of lacosamide monotherapy versus controlled-release carbamazepine in patients with newly diagnosed epilepsy: a phase 3, randomised, double-blind, non-inferiority trial // Lancet Neurol. Lancet Publishing Group, 2017. Vol. 16, № 1. P. 43-54. 279. Marson A.G. et al. Carbamazepine versus valproate monotherapy for epilepsy // Cochrane Database Syst. Rev. Wiley, 2000. Vol. 2000, № 3. 225 280. Nevitt S.J. et al. Topiramate versus carbamazepine monotherapy for epilepsy: An individual participant data review // Cochrane Database of Systematic Reviews. John Wiley and Sons Ltd, 2019. Vol. 2019, № 6. 281. Nevitt S.J. et al. Lamotrigine versus carbamazepine monotherapy for epilepsy: An individual participant data review // Cochrane Database of Systematic Reviews. John Wiley and Sons Ltd, 2018. Vol. 2018, № 6. 282. Brodie M.J. et al. Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy // Neurology. Neurology, 2007. Vol. 68, № 6. P. 402–408. 283. Trinka E. et al. KOMET: An unblinded, randomised, two parallelgroup, stratified trial comparing the effectiveness of levetiracetam with controlled-release carbamazepine and extended-release sodium valproate as monotherapy in patients with newly diagnosed epilepsy // J. Neurol. Neurosurg. Psychiatry. BMJ Publishing Group, 2013. Vol. 84, № 10. P. 1138–1147. 284. Marson A. et al. The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: An unblinded randomised controlled trial // Lancet. 2007. Vol. 369. P. 1016–1026. 285. Glauser T. et al. Updated ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes // Epilepsia. Epilepsia, 2013. Vol. 54, № 3. P. 551–563. 286. Brigo F. et al. Clonazepam monotherapy for treating people with newly diagnosed epilepsy // Cochrane Database of Systematic Reviews. John Wiley and Sons Ltd, 2019. Vol. 2019, № 11. 287. Lattanzi S. et al. Antiepileptic drug monotherapy for epilepsy in the elderly: A systematic review and network meta-analysis // Epilepsia. Blackwell Publishing Inc., 2019. Vol. 60, № 11. P. 2245–2254. 288. Rowan A.J. et al. New onset geriatric epilepsy: A randomized study of gabapentin, lamotrigine, and carbamazepine // Neurology. Lippincott Williams and Wilkins, 2005. Vol. 64, № 11. P. 1868–1873. 289. Авакян Г.Н. et al. Ограничения использования вальпроевой кислоты у девочек и женщин: расширение противопоказаний в инструкции по медицинскому применению, основанное на данных реальной клинической практики // Эпилепсия и пароксизмальные состояния. Общество с ограниченной ответственностью «Ирбис», 2019. Vol. 11, № 2. 290. Liu J., Wang L.N., Wang Y.P. Topiramate monotherapy for juvenile myoclonicepilepsy // Cochrane Database of Systematic Reviews. John Wiley and Sons Ltd, 2017. Vol. 2017, № 4. 226 291. Wiebe S., Jette N. Pharmacoresistance and the role of surgery in difficult to treat epilepsy // Nat. Rev. Neurol. Nat Rev Neurol, 2012. Vol. 8, № 12. P. 669–677. 292. Bodalia P.N. et al. Comparative efficacy and tolerability of anti-epileptic drugs for refractory focal epilepsy: Systematic review and network meta-analysis reveals the need for long term comparator trials // Br. J. Clin. Pharmacol. Br J Clin Pharmacol, 2013. Vol. 76, № 5. P. 649–667. 293. Ma J., Huang S., You C. Adjunctive brivaracetam for patients with refractory partial seizures: A meta-analysis of randomized placebo-controlled trials // Epilepsy Res. Elsevier, 2015. Vol. 114. P. 59–65. 294. French J.A. et al. Evaluation of adjunctive perampanel in patients with refractory partial-onset seizures: Results of randomized global phase III study 305 // Epilepsia. Epilepsia, 2013. Vol. 54, № 1. P. 117–125. 295. Elger C. et al. Efficacy and safety of eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures: A randomized, double-blind, placebo- controlled, parallel-group phase III study // Epilepsia. Epilepsia, 2009. Vol. 50, № 3. P. 454–463. 296. Song L. et al. Clonazepam add-on therapy for drug-resistant epilepsy // Cochrane Database of Systematic Reviews. John Wiley and Sons Ltd, 2020. Vol. 2020, № 4. 297. Colleran N., O Connor T., O Brien J.J. Anti epileptic drug trials for patients with drug resistant idiopathic generalised epilepsy: A meta-analysis // Seizure. W.B. Saunders Ltd, 2017. Vol. 51. P. 145–156. 298. Marson A. et al. The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial // Lancet. Elsevier B.V., 2021. Vol. 397, № 10282. P. 1375–1386. 299. Воронкова К.В. и др. Современный выбор антиэпилептической терапии: этапы и рекомендации //Эпилепсия и пароксизмальные состояния. – 2018. – Т. 10. – №. 2. 300. Booth D., Evans D.J. Anticonvulsants for neonates with seizures // Cochrane Database Syst. Rev. Wiley, 2004. № 4. 301. Ijff D.M., Aldenkamp A.P. Cognitive side-effects of antiepileptic drugs in children // Handbook of Clinical Neurology. Elsevier B.V., 2013. Vol. 111. P. 707–718. 302. Bensch J. et al. A Double blind Study of Clonazepam in the Treatment of ‐ Therapy resistant Epilepsy in Children // Dev. Med. Child Neurol. Dev Med Child Neurol, 1977. ‐ Vol. 19, № 3. P. 335–342. 227 303. Guerreiro M.M. et al. A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in children and adolescents with epilepsy // Epilepsy Res. Epilepsy Res, 1997. Vol. 27, № 3. P. 205–213. 304. Glauser TA et al. Adjunctive therapy with oxcarbazepine in children with partial seizures. The Oxcarbazepine Pediatric Study Group. Neurology. 2000; 54(12):2237–44. 305. Bittencourt PR, Antoniuk SA, Bigarella MM, da Costa JC, Doro MP, Ferreira AS, et al. Carbamazepine and phenytoin in epilepsies refractory to barbiturates: efficacy, toxicity and mental function. Epilepsy Res. 1993;16(2):147–55 306. Wheless J.W. et al. Treatment of pediatric epilepsy: European expert opinion, 2007 // Epileptic Disord. Epileptic Disord, 2007. Vol. 9, № 4. P. 353–412. 307. Pina-Garza J.E.; Nordli D.R.; Rating D.; Yang H.; Schiemann-Delgado J.; Duncan B.; Adjunctive levetiracetam in infants and young children with refractory partial-onset seizures; Epilepsia;2009;50;5:1141-1149 308. Glauser T.A. et al. Double-blind placebo-controlled trial of adjunctive levetiracetam in pediatric partial seizures // Neurology. Neurology, 2006. Vol. 66, № 11. P. 1654–1660. 309. Rosenfeld W.E. et al. Levetiracetam as add-on therapy for idiopathic generalized epilepsy syndromes with onset during adolescence: Analysis of two randomized, double-blind, placebo-controlled studies // Epilepsy Res. Epilepsy Res, 2009. Vol. 85, № 1. P. 72–80. 310. Arzimanoglou A, Ferreira J, Satlin A, Olhaye O, Kumar D, Dhadda S, Bibbiani F. Evaluation of long-term safety, tolerability, and behavioral outcomes with adjunctive rufinamide in pediatric patients (≥1 to <4 years old) with Lennox-Gastaut syndrome: Final results from randomized study 303. Eur J Paediatr Neurol. 2019 Jan;23(1):126-135. 311. Ohtsuka Y. et al. Rufinamide as an adjunctive therapy for Lennox-Gastaut syndrome: A randomized double-blind placebo-controlled trial in Japan // Epilepsy Res. Elsevier B.V., 2014. Vol. 108, № 9. P. 1627–1636. 312. Gilliam FG, Veloso F, Bomhof MA, Gazda SK, Biton V, Ter Bruggen JP, Neto W, Bailey C, Pledger G, Wu SC. A dose-comparison trial of topiramate as monotherapy in recently diagnosed partial epilepsy. Neurology. 2003 Jan 28;60(2):196-202. doi: 10.1212/01.wnl.0000048200.12663.bc. PMID: 12552030. 313. Sachdeo R.C. et al. A double-blind, randomized trial of topiramate in Lennox- Gastaut syndrome // Neurology. Lippincott Williams and Wilkins, 1999. Vol. 52, № 9. P. 1882– 1887. 314. Frank L.M. et al. Lamictal (lamotrigine) monotherapy for typical absence seizures in children // Epilepsia. Lippincott Williams and Wilkins, 1999. Vol. 40, № 7. P. 973–979. 228 315. Smith D, Baker G, Davies G, Dewey M, Chadwick DW. Outcomes of add-on treatment with lamotrigine in partial epilepsy. Epilepsia. 1993 Mar-Apr;34(2):312-22. doi: 10.1111/j.1528-1157.1993.tb02417.x. PMID: 8453943 316. Duchowny M. et al. A placebo-controlled trial of lamotrigine add-on therapy for partial seizures in children // Neurology. Lippincott Williams and Wilkins, 1999. Vol. 53, № 8. P. 1724–1731. 317. Trevathan E. et al. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures // Pediatrics. Pediatrics, 2006. Vol. 118, № 2. 318. Motte J. et al. Lamotrigine for Generalized Seizures Associated with the Lennox– Gastaut Syndrome // N. Engl. J. Med. New England Journal of Medicine (NEJM/MMS), 1997. Vol. 337, № 25. P. 1807–1812. 319. Белоусова Е.Д., Шулякова И.В., Охапкина Т.Г. Гормональная терапия синдрома Веста // Журнал неврологии и психиатрии им. C.C. Корсакова. Общество с ограниченной ответственностью Издательство Медиа Сфера, 2016. Vol. 116, № 9–2. P. 61– 66. 320. Guerrini R. Et al. A randomized phase III trial of adjunctive zonisamide in pediatric patients with partial epilepsy // Epilepsia. Epilepsia, 2013. Vol. 54, № 8. P. 1473–1480. 321. Brigo F., Igwe S.C. Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents // Cochrane Database of Systematic Reviews. John Wiley and Sons Ltd, 2017. Vol. 2017, № 2. 322. Wallace S.J. Myoclonus and epilepsy in childhood: A review of treatment with valproate, ethosuximide, lamotrigine and zonisamide // Epilepsy Res. Epilepsy Res, 1998. Vol. 29, № 2. P. 147–154. 323. Krauss G.L. et al. Randomized phase III study 306 Adjunctive perampanel for refractory partial-onset seizures // Neurology. Lippincott Williams and Wilkins, 2012. Vol. 78, № 18. P. 1408–1415. 324. French J.A. et al. Perampanel for tonic-clonic seizures in idiopathic generalized epilepsy. A randomized trial // Neurology. Lippincott Williams and Wilkins, 2015. Vol. 85, № 11. P. 950–957. 325. Fogarasi A. et al. Open-label study to investigate the safety and efficacy of adjunctive perampanel in pediatric patients (4 to <12 years) with inadequately controlled focal seizures or generalized tonic-clonic seizures // Epilepsia. Blackwell Publishing Inc., 2020. Vol. 61, № 1. P. 125–137. 229 326. Farkas V. et al. Efficacy and tolerability of adjunctive lacosamide in pediatric patients with focal seizures // Neurology. Neurology, 2019. Vol. 93, № 12. P. E1212–E1226. 327. Chadwick D.W. et al. A double-blind trial of gabapentin monotherapy for newly diagnosed partial seizures // Neurology. Lippincott Williams and Wilkins, 1998. Vol. 51, № 5. P. 1282–1288. 328. Panebianco M. et al. Gabapentin add-on treatment for drug-resistant focal epilepsy // Cochrane Database of Systematic Reviews. John Wiley and Sons Ltd, 2018. Vol. 2018, № 10. 329. Klein P. et al. A randomized, double-blind, placebo-controlled, multicenter, parallel-group study to evaluate the efficacy and safety of adjunctive brivaracetam in adult patients with uncontrolled partial-onset seizures // Epilepsia. Blackwell Publishing Inc., 2015. Vol. 56, № 12. P. 1890–1898. 330. Bresnahan R. et al. Clobazam add-on therapy for drug-resistant epilepsy // Cochrane Database of Systematic Reviews. John Wiley and Sons Ltd, 2019. Vol. 2019, № 10. 331. Ng Y.T. et al. Randomized, phase III study results of clobazam in Lennox-Gastaut syndrome // Neurology. Lippincott Williams and Wilkins, 2011. Vol. 77, № 15. P. 1473–1481. 332. Sofou K, Kristjánsdóttir R, Papachatzakis NE, Ahmadzadeh A, Uvebrant P.J Management of prolonged seizures and status epilepticus in childhood: a systematic review. Child Neurol. 2009 Aug;24(8):918-26. doi: 10.1177/0883073809332768. Epub 2009 Mar 30 333. Wolf P. Acute Drug Administration in Epilepsy: A Review // CNS Neurosci. Ther. CNS Neurosci Ther, 2011. Vol. 17, № 5. P. 442–448. 334. Brigo F. et al. Nonintravenous midazolam versus intravenous or rectal diazepam for the treatment of early status epilepticus: A systematic review with meta-analysis // Epilepsy Behav. Epilepsy Behav, 2015. Vol. 49. P. 325–336. 335. Pavlidou E., Tzitiridou M., Panteliadis C. Effectiveness of intermittent diazepam prophylaxis in febrile seizures: Long-term prospective controlled study // J. Child Neurol. J Child Neurol, 2006. Vol. 21, № 12. P. 1036–1040. 336. McIntyre J. et al. Safety and efficacy of buccal midazolam versus rectal diazepam for emergency treatment of seizures in children: A randomised controlled trial // Lancet. Elsevier B.V., 2005. Vol. 366, № 9481. P. 205–210. 337. Li S. et al. Prednisolone/prednisone as adrenocorticotropic hormone alternative for infantile spasms: a meta-analysis of randomized controlled trials // Developmental Medicine and Child Neurology. Blackwell Publishing Ltd, 2020. Vol. 62, № 5. P. 575–580. 338. Rajpurohit M. et al. Safety, Feasibility and Effectiveness of Pulse Methylprednisolone Therapy in Comparison with Intramuscular Adrenocorticotropic Hormone in Children with West Syndrome // Indian J. Pediatr. Springer, 2020. 230 339. Haberlandt E. et al. Adrenocorticotropic Hormone versus Pulsatile Dexamethasone in the Treatment of Infantile Epilepsy Syndromes // Pediatr. Neurol. Pediatr Neurol, 2010. Vol. 42, № 1. P. 21–27. 340. Прыгунова Т.М. Синдром Веста: отдаленные исходы в зависимости от этиологии и лечения (обзор литературы) // Русский журнал детской неврологии. Общество с ограниченной ответственностью «Издательский дом «АБВ-пресс», 2018. Vol. 13, № 4. 341. Coughlin CR 2nd, Tseng LA, Abdenur JE, Ashmore C, Boemer F, Bok LA, Boyer M, Buhas D, Clayton PT, Das A, Dekker H, Evangeliou A, Feillet F, Footitt EJ, Gospe SM Jr, Hartmann H, Kara M, Kristensen E, Lee J, Lilje R, Longo N, Lunsing RJ, Mills P, Papadopoulou MT, Pearl PL, Piazzon F, Plecko B, Saini AG, Santra S, Sjarif DR, Stockler-Ipsiroglu S, Striano P, Van Hove JLK, Verhoeven-Duif NM, Wijburg FA, Zuberi SM, van Karnebeek CDM. Consensus guidelines for the diagnosis and management of pyridoxine-dependent epilepsy due to α-aminoadipic semialdehyde dehydrogenase deficiency. J Inherit Metab Dis. 2021 Jan;44(1):178-192. doi: 10.1002/jimd.12332. Epub 2020 Dec 1. PMID: 33200442. 342. Шалькевич Л.В., Шанько Г.Г., Кот Д.А. Кортикостероидная терапия фармакорезистентных эпилепсий у детей // Международный неврологический журнал. ФЛП «Заславский Александр Юрьевич», 2014. № 3 (65). P. 20–27. 343. deVries E.E. et al. Inflammatory mediators in human epilepsy: A systematic review and meta-analysis // Neuroscience and Biobehavioral Reviews. ElsevierLtd, 2016. Vol. 63. P. 177–190. 344. Белоусова Е.Д., Ермаков A.Ю. Эпилептическая энцефалопатия с продолженной спайк-волновой активностью во сне: обзор литературы // Журнал неврологии и психиатрии им. ССКорсакова. Спецвыпуски. Издательство ’МедиаСфера’, 2014. Vol. 114, № 4. P. 52–58. 345. Iizuka T, Kanazawa N, Kaneko J, Tominaga N, Nonoda Y, Hara A, Onozawa Y, Asari H, Hata T, Kaneko J, Yoshida K, Sugiura Y, Ugawa Y, Watanabe M, Tomita H, Kosakai A, Kaneko A, Ishima D, Kitamura E, Nishiyama K. Cryptogenic NORSE: Its distinctive clinical features and response to immunotherapy. Neurol Neuroimmunol Neuroinflamm. 2017 Sep 25;4(6):e396. doi: 10.1212/NXI.0000000000000396. PMID: 28959704; PMCID: PMC5614728. 346. Белоусова Е.Д., Яблонская М.И., Тагирова М.К. и соавт. Иммунообусловленные эпилепсии у детей // Российский вестник перинатологии и педиатрии, 2015. Vol. 60, № 5. P. 26–32. 347. NabboutR. еt al. Efficacy of ketogenic diet in severe refractory status epilepticus initiating fever induced refractory epileptic encephalopathy in school age children (FIRES) // Epilepsia. Epilepsia, 2010. Vol. 51, № 10. P. 2033–2037. 231 348. Bello-Espinosa LE, Rajapakse T, Rho JM, Buchhalter J. Efficacy of intravenous immunoglobulin in a cohort of children with drug-resistant epilepsy. Pediatr Neurol. 2015 May;52(5):509-16. doi: 10.1016/j.pediatrneurol.2014.11.011. Epub 2015 Feb 13. PMID: 25882078. 349. Rezaei S. et al. Short-term and long-term efficacy of classical ketogenic diet and modified Atkins diet in children and adolescents with epilepsy: A systematic review and meta- analysis // Nutritional Neuroscience. Taylor and Francis Ltd., 2019. Vol. 22, № 5. P. 317–334. 350. Englot D.J., Chang E.F., Auguste K.I. Vagus nerve stimulation for epilepsy: A meta-analysis of efficacy and predictors of response - A review // Journal of Neurosurgery. J Neurosurg, 2011. Vol. 115, № 6. P. 1248–1255. 351. Maragkos G.A. et al. Quality of Life after Epilepsy Surgery in Children: A Systematic Review and Meta-Analysis // Clinical Neurosurgery. Oxford University Press, 2019. Vol. 85, № 6. P. 741–749. 352. Tomson T. et al. Executive Summary: Management of epilepsy in pregnancy: A report from the International League Against Epilepsy Task Force on Women and Pregnancy // Epilepsia. Blackwell Publishing Inc., 2019. Vol. 60, № 12. P. 2343–2345. 353. Thomas S. V., Syam U., Devi J.S. Predictors of seizures during pregnancy in women with epilepsy // Epilepsia. 2012. Vol. 53, № 5. 354. Vajda F.J.E. et al. Seizure control in antiepileptic drug-treated pregnancy // Epilepsia. Blackwell Publishing Inc., 2008. Vol. 49, № 1. P. 172–176. 355. Battino D. et al. Seizure control and treatment changes in pregnancy: Observations from the EURAP epilepsy pregnancy registry // Epilepsia. Epilepsia, 2013. Vol. 54, № 9. P. 1621–1627. 356. Hiilesmaa V.K., Teramo K.A. Fetal and Maternal Risks with Seizures // Epilepsy in Women. John Wiley and Sons, 2013. P. 115–127. 357. Edey S., Moran N., Nashef L. SUDEP and epilepsy-related mortality in pregnancy // Epilepsia. Blackwell Publishing Inc., 2014. Vol. 55, № 7. 358. EURAP - International Registry of Antiepileptic Drugs and Pregnancy [Electronic resource]. URL: https://eurapinternational.org/ (accessed: 30.05.2021). 359. Tomson T., Battino D., Perucca E. Teratogenicity of antiepileptic drugs // Curr. Opin. Neurol. Lippincott Williams and Wilkins, 2019. Vol. 32, № 2. P. 246–252. 360. Blotière P.O. et al. Risks of 23 specific malformations associated with prenatal exposure to 10 antiepileptic drugs // Neurology. Lippincott Williams and Wilkins, 2019. Vol. 93, № 2. P. E167–E180. 232 361. Карлов В.А. et al. Эпилепсия и беременность // Эпилепсия у детей и взрослых женщин и мужчин. Второе издание / ed. Карлов В.А. Москва: Издательство БИНОМ, 2019. P. 672–690. 362. Карлов В.А., Бурд С.Г., Михаловска-Карлова Е.П. Современность и эпилепсия. Современные и биоэтические аспекты эпилепсии. // Эпилепсия у детей и взрослых женщин и мужчин». Руководство для врачей. Второе издание. / ed. Карлов В.А. Москва: Издательство БИНОМ, 2019. P. 868–891. 363. Власов П.Н. Применение противоэпилептических препаратов во время беременности // Фармакотерапия отдельных состояний при беременности / ed. Володин Н.Н., Белоусов Ю.Б., Зырянов С.К. Москва: Миклош, 2012. P. 127–137. 364. Pariente G. Et al. Pregnancy Outcomes Following In Utero Exposure to Lamotrigine: A Systematic Review and Meta-Analysis // CNS Drugs. Adis, 2017. Vol. 31, № 6. P. 439–450. 365. Veroniki A.A. et al. Comparative safety of anti-epileptic drugs during pregnancy: A systematic review and network meta-analysis of congenital malformations and prenatal outcomes // BMC Med. BioMed Central Ltd., 2017. Vol. 15, № 1. 366. Morrow J.I. et al. Folic acid use and major congenital malformations in offspring of women with epilepsy: A prospective study from the UK Epilepsy and pregnancy register // J. Neurol. Neurosurg. Psychiatry. J Neurol Neurosurg Psychiatry, 2009. Vol. 80, № 5. P. 506–511. 367. Tomson T. et al. Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry // Lancet Neurol. Lancet Publishing Group, 2018. Vol. 17, № 6. P. 530–538. 368. Meador K.J. et al. Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): A prospective observational study // Lancet Neurol. Lancet Neurol, 2013. Vol. 12, № 3. P. 244–252 369. Minicucci F., Ferlisi M., Brigo F., Mecarelli O., Meletti S., Aguglia U., Michelucci R., Mastrangelo M., Specchio N., Sartori S., Tinuper P. Management of status epilepticus in adults. Position paper of the Italian League against Epilepsy. Epilepsy & Behavior 102 (2020) 370. Kilbride R.D., Reynolds A.S., Szaflarski J.P., Hirsch L.J. Clinical outcomes following prolonged refractory status epilepticus (PRSE). Neurocrit Care 2013; 18 (3):374-385. 371. Özkara Ç. et al. Surgical outcome of epilepsy patients evaluated with a noninvasive protocol // Epilepsia. Lippincott Williams and Wilkins, 2000. Vol. 41, № SUPPL. 4. 372. Jette N., Reid A.Y., Wiebe S. Surgical management of epilepsy // CMAJ. Canadian Medical Association, 2014. Vol. 186, № 13. P. 997–1004. 233 373. Wiebe S., Jette N. Pharmacoresistance and the role of surgery in difficult to treat epilepsy // Nat. Rev. Neurol. Nat Rev Neurol, 2012. Vol. 8, № 12. P. 669–677. 374. Spencer S., Huh L. Outcomes of epilepsy surgery in adults and children // Lancet Neurol. Lancet Neurol, 2008. Vol. 7, № 6. P. 525–537. 375. Spencer S.S. et al. Health-related quality of life over time since resective epilepsy surgery // Ann. Neurol. Ann Neurol, 2007. Vol. 62, № 4. P. 327–334. 376. Ryvlin P., Cross J.H., Rheims S. Epilepsy surgery in children and adults // Lancet Neurol. Lancet Publishing Group, 2014. Vol. 13, № 11. P. 1114–1126. 377. Velasco A.L. et al. Electrical stimulation of the hippocampal epileptic foci for seizure control: A double-blind, long-term follow-up study // Epilepsia. Epilepsia, 2007. Vol. 48, № 10. P. 1895–1903. 378. Neligan A. et al. A survey of adult and pediatric epilepsy surgery in the United Kingdom // Epilepsia. Epilepsia, 2013. Vol. 54, № 5. 379. Niemeyer P. The transventricular amygdalohippocampectomy in temporal lobe epilepsy // Temporal lobe epilepsy. Charles C Thomas, 1958. P. 461–482. 380. Vakharia V.N. et al. Getting the best outcomes from epilepsy surgery // Ann. Neurol. John Wiley and Sons Inc., 2018. Vol. 83, № 4. P. 676–690. 381. Crandall P.H. Standard en bloc anterior temporal lobectomy // Surgery for epilepsy. Blackwell Scientific Publications, Boston, 1991. P. 118–129. 382. Wyler A.R. Anterior temporal lobectomy // Surg. Neurol. Surg Neurol, 2000. Vol. 54, № 5. P. 341–345. 383. Wen H.T. et al. Microsurgical anatomy of the temporal lobe: Part 1: Mesial temporal lobe anatomy and its vascular relationships as applied to amygdalohippocampectomy // Neurosurgery. Lippincott Williams and Wilkins, 1999. Vol. 45, № 3. P. 549–592. 384. Spencer D.D. et al. Access to the posterior medial temporal lobe structures in the surgical treatment of temporal lobe epilepsy // Neurosurgery. Neurosurgery, 1984. Vol. 15, № 5. P. 667–671. 385. Noachtar S., Borggraefe I. Epilepsy surgery: A critical review // Epilepsy Behav. Epilepsy Behav, 2009. Vol. 15, № 1. P. 66–72. 386. Connor D.E. et al. Vagal nerve stimulation for the treatment of medically refractory epilepsy: A review of the current literature // Neurosurg. Focus. Neurosurg Focus, 2012. Vol. 32, № 3. 387. Morris G.L. et al. Evidence-based guideline update: Vagus nerve stimulation for the treatment of epilepsy: Report of the guideline development subcommittee of the american academy of neurology // Neurology. Neurology, 2013. Vol. 81, № 16. P. 1453–1459. 234 388. Manuals « VNS Therapy « Healthcare Professionals, on VNS Therapy for Epilepsy | Cyberonics US [Electronic resource]. URL: https://dynamic.cyberonics.com/manuals/index_iframe_test.asp?lang=English-US (accessed: 30.05.2021). 389. Josephson C.B. et al. Systematic review and meta-analysis of standard vs selective temporal lobe epilepsy surgery // Neurology. Neurology, 2013. Vol. 80, № 18. P. 1669–1676. 390. Morrell F., Whisler W.W., Bleck T.P. Multiple subpial transection: A new approach to the surgical treatment of focal epilepsy // J. Neurosurg. J Neurosurg, 1989. Vol. 70, № 2. P. 231–239. 391. Spencer S.S. et al. Multiple subpial transection for intractable partial epilepsy: An international meta-analysis // Epilepsia. Epilepsia, 2002. Vol. 43, № 2. P. 141–145. 392. Hufnagel A. et al. Multiple subpial transection for control of epileptic seizures: Effectiveness and safety // Epilepsia. Epilepsia, 1997. Vol. 38, № 6. P. 678–688. 393. Gates J.R. et al. Response of Multiple Seizure Types to Corpus Callosum Section // Epilepsia. Epilepsia, 1987. Vol. 28, № 1. P. 28–34. 394. Wilson D.H., Reeves A.G., Gazzaniga M.S. “Central” commissurotomy for intractable generalized epilepsy: Series two // Neurology. Neurology, 1982. Vol. 32, № 7. P. 687–697. 395. Wyllie E. Catastrophic epilepsy in infants and children: Identification of surgical candidates // Epileptic Disord. Epileptic Disord, 1999. Vol. 1, № 4. P. 261–264. 396. Carreño M. et al. Intractable epilepsy in vascular congenital hemiparesis: Clinical features and surgical options // Neurology. Lippincott Williams and Wilkins, 2002. Vol. 59, № 1. P. 129–131. 397. González-Martínez J.A. et al. Hemispherectomy for catastrophic epilepsy in infants // Epilepsia. Epilepsia, 2005. Vol. 46, № 9. P. 1518–1525. 398. Elsharkawy A.E. et al. Outcome of extratemporal epilepsy surgery experience of a single center // Neurosurgery. Neurosurgery, 2008. Vol. 63, № 3. P. 516–525. 399. Крылов В.В. Хирургия эпилепсии. АБВ-пресс, 2019. 400. Bauer S., Hamer H.M. Extratemporal epilepsies // Handbook of Clinical Neurology. Elsevier B.V., 2012. Vol. 107. P. 241–256. 401. Greiner H.M. et al. Preresection intraoperative electrocorticography (ECoG) abnormalities predict seizure-onset zone and outcome in pediatric epilepsy surgery // Epilepsia. Blackwell Publishing Inc., 2016. Vol. 57, № 4. P. 582–589. 235 402. Kaufmann E. et al. European Expert Opinion on ANT-DBS therapy for patients with drug-resistant epilepsy (a Delphi consensus) // Seizure. W.B. Saunders Ltd, 2020. Vol. 81. P. 201–209. 403. Salanova V. et al. Long-term efficacy and safety of thalamic stimulation for drug- resistant partial epilepsy // Neurology. Lippincott Williams and Wilkins, 2015. Vol. 84, № 10. P. 1017–1025. 404. Parent M., Parent A. Single-axon tracing and three-dimensional reconstruction of centre médian-parafascicular thalamic neurons in primates // J. Comp. Neurol. J Comp Neurol, 2005. Vol. 481, № 1. P. 127–144. 405. Handforth A., DeSalles A.A.F., Krahl S.E. Deep brain stimulation of the subthalamic nucleus as adjunct treatment for refractory epilepsy // Epilepsia. Epilepsia, 2006. Vol. 47, № 7. P. 1239–1241. 406. Wellmer J., Voges J., Parpaley Y. Lesion guided radiofrequency thermocoagulation (L-RFTC) for hypothalamic hamartomas, nodular heterotopias and cortical dysplasias: Review and perspective // Seizure. W.B. Saunders Ltd, 2016. Vol. 41. P. 206–210. 407. Kameyama S. et al. MRI-guided stereotactic radiofrequency thermocoagulation for 100 hypothalamic hamartomas // J. Neurosurg. American Association of Neurological Surgeons, 2016. Vol. 124, № 5. P. 1503–1512. 408. Catenoix H. et al. SEEG-guided thermocoagulations: A palliative treatment of nonoperable partial epilepsies // Neurology. Lippincott Williams and Wilkins, 2008. Vol. 71, № 21. P. 1719–1726. 409. Gopinath S. et al. Seizure outcome following primary motor cortex-sparing resective surgery for perirolandic focal cortical dysplasia // Int. J. Surg. Elsevier Ltd, 2016. Vol. 36, № Pt B. P. 466–476. 410. Mula M., Sander J.W. Current and emerging drug therapies for the treatment of depression in adults with epilepsy // Expert Opinion on Pharmacotherapy. Taylor and Francis Ltd, 2019. Vol. 20, № 1. P. 41–45. 411. Orjuela-Rojas J.M. et al. Treatment of depression in patients with temporal lobe epilepsy: A pilot study of cognitive behavioral therapy vs. selective serotonin reuptake inhibitors // Epilepsy Behav. Academic Press Inc., 2015. Vol. 51. P. 176–181. 412. Li W., Ma D. A randomized controlled trial to evaluate the efficacy of paroxetine and doxepin in treating epileptic patients with depression // Zhong Linch Kangfu. 2005. Vol. 9. P. 20–21. 413. Усюкина М.В. Систематика и принципы терапии депрессивных расстройств при эпилепсии// Нервно-мышечные болезни. 2015. №4. URL: 236 https://cyberleninka.ru/article/n/sistematika-i-printsipy-terapii-depressivnyh-rasstroystv-pri- epilepsii (дата обращения: 16.07.2021). 414. Hovorka J., Herman E., Nemcová I. Treatment of interictal depression with citalopram in patients with epilepsy // Epilepsy Behav. Epilepsy Behav, 2000. Vol. 1, № 6. P. 444–447. 415. Specchio L.M. et al. Citalopram as treatment of depression in patients with epilepsy // Clin. Neuropharmacol. Clin Neuropharmacol, 2004. Vol. 27, № 3. P. 133–136. 416. Kühn K.U. et al. Antidepressive treatment in patients with temporal lobe epilepsy and major depression: A prospective study with three different antidepressants // Epilepsy Behav. Academic Press Inc., 2003. Vol. 4, № 6. P. 674–679. 417. Gilliam F.G. et al. A Trial of Sertraline or Cognitive Behavior Therapy for Depression in Epilepsy // Ann. Neurol. John Wiley and Sons Inc., 2019. Vol. 86, № 4. P. 552– 560. 418. Kanner A.M., Kozak A.M., Frey M. The use of sertraline in patients with epilepsy: Is it safe? // Epilepsy Behav. Epilepsy Behav, 2000. Vol. 1, № 2. P. 100–105. 419. Zhu S.Q., Luo L.J., YaX G. Short-Term efficacy of venlafaxine treating the depression in epilepsy patients // Chin J Rehabil. 2004. Vol. 19. P. 101. 420. Носов С.Г. Депрессия и эпилепсия: общие патогенетические закономерности развития и особенности лечения (обзор литературы) //Український вісник психоневрології. – 2012. – Т. 20. – №. 4. – С. 92- 421. Robertson M.M., Trimble M.R. The treatment of depression in patients with epilepsy A double-blind trial // J. Affect. Disord. J Affect Disord, 1985. Vol. 9, № 2. P. 127–136. 422. Alper K. et al. Seizure Incidence in Psychopharmacological Clinical Trials: An Analysis of Food and Drug Administration (FDA) Summary Basis of Approval Reports // Biol. Psychiatry. Biol Psychiatry, 2007. Vol. 62, № 4. P. 345–354. 423. Italiano D., Spina E., De Leon J. Pharmacokinetic and pharmacodynamic interactions between antiepileptics and antidepressants // Expert Opin. Drug Metab. Toxicol. Informa Healthcare, 2014. Vol. 10, № 11. P. 1457–1489. 424. Unterecker S. et al. Interaction of valproic acid and the antidepressant drugs doxepin and venlafaxine: Analysis of therapeutic drug monitoring data under naturalistic conditions // Int. Clin. Psychopharmacol. Lippincott Williams and Wilkins, 2014. Vol. 29, № 4. P. 206–211. 425. Hemeryck A., Belpaire F. Selective Serotonin Reuptake Inhibitors and Cytochrome P-450 Mediated Drug-Drug Interactions: An Update // Curr. Drug Metab. Bentham Science Publishers Ltd., 2002. Vol. 3, № 1. P. 13–37. 237 426. Berigan T., Harazin J. A sertraline/valproic acid drug interaction // Int. J. Psychiatry Clin. Pract. Martin Dunitz Ltd, 1999. Vol. 3, № 4. P. 287–288. 427. Macrodimitris S. et al. Group cognitive-behavioral therapy for patients with epilepsy and comorbid depression and anxiety // Epilepsy Behav. Epilepsy Behav, 2011. Vol. 11, № 1. P. 83–88. 428. Gandy M. et al. A feasibility trial of an Internet-delivered and transdiagnostic cognitive behavioral therapy treatment program for anxiety, depression, and disability among adults with epilepsy // Epilepsia. Blackwell Publishing Inc., 2016. Vol. 57, № 11. P. 1887–1896. 429. Пешеходько Д. И. Депрессия и тревожность при детской эпилепсии: обзорный анализ / Д.И. Пешеходько, Б.Д. Абдулазизов, А.А. Некишева // Перспективы науки. – 2020. – № 12(135). – С. 206-208. 430. Mula M. Pharmacological treatment of anxiety disorders in adults with epilepsy // Expert Opin. Pharmacother. Taylor and Francis Ltd, 2018. Vol. 19, № 17. P. 1867–1874. 431. Mula M. Treatment of anxiety disorders in epilepsy: An evidence-based approach // Epilepsia. Epilepsia, 2013. Vol. 54, № SUPPL. 1. P. 13–18. 432. Sepúlveda C. et al. Palliative care: The world health organization’s global perspective // J. Pain Symptom Manage. Elsevier Inc., 2002. Vol. 24, № 2. P. 91–96. 433. Pastrana T. et al. A matter of definition - Key elements identified in a discourse analysis of definitions of palliative care // Palliat. Med. Palliat Med, 2008. Vol. 22, № 3. P. 222– 232. 434. Glauser T. et al. Evidence-based guideline: Treatment of convulsive status epilepticus in children and adults: Report of the guideline committee of the American epilepsy society // Epilepsy Currents. American Epilepsy Society, 2016. Vol. 16, № 1. P. 48–61. 435. Kossoff EH, Zupec-Kania BA, Auvin S, et al. Optimal clinical management of children receiving dietary therapies for epilepsy: Updated recommendations of the International Ketogenic Diet Study Group. Epilepsia Open. 2018;3(2):175-192. Published 2018 May 21. doi:10.1002/epi4.12225 436. D'Andrea Meira I, Romão TT, Pires do Prado HJ, Krüger LT, Pires MEP, da Conceição PO. Ketogenic Diet and Epilepsy: What We Know So Far. Front Neurosci. 2019;13:5. Published 2019 Jan 29. doi:10.3389/fnins.2019.00005 437. Vancampfort D., Ward P.B., Stubbs B. Physical fitness levels and moderators in people with epilepsy: A systematic review and meta-analysis // Epilepsy Behav. Academic Press Inc., 2019. Vol. 99. 238 438. Vancampfort D., Ward P.B., Stubbs B. Physical activity and sedentary levels among people living with epilepsy: A systematic review and meta-analysis // Epilepsy Behav. Academic Press Inc., 2019. Vol. 99. 439. Deng B.W. et al. A Meta-analysis of the Effectiveness of Acupuncture in the Treatment of Epilepsy // Zhen ci yan jiu = Acupunct. Res. NLM (Medline), 2018. Vol. 43, № 4. P. 263–268. 440. Nakken K.O., Brodtkorb E., Koht J. Epilepsi og rehabilitering // Tidsskr. Den Nor. legeforening. 2007. 441. Helde G. et al. An easily performed group education programme for patients with uncontrolled epilepsy - A pilot study // Seizure. W.B. Saunders Ltd, 2003. Vol. 12, № 7. P. 497– 501. 442. Helde G. et al. A structured, nurse-led intervention program improves quality of life in patients with epilepsy: A randomized, controlled trial // Epilepsy Behav. Epilepsy Behav, 2005. Vol. 7, № 3. P. 451–457. 443. Michaelis R. et al. Psychological treatments for people with epilepsy // Cochrane Database Syst. Rev. John Wiley and Sons Ltd, 2017. Vol. 2017, № 10. 444. Haut S.R., Gursky J.M., Privitera M. Behavioral interventions in epilepsy // Curr. Opin. Neurol. Lippincott Williams and Wilkins, 2019. Vol. 32, № 2. P. 227–236. 445. Schröder J. et al. Efficacy of a psychological online intervention for depression in people with epilepsy: A randomized controlled trial // Epilepsia. Epilepsia, 2014. Vol. 55, № 12. P. 2069–2076. 446. Meyer B. et al. Effects of an epilepsy-specific Internet intervention (Emyna) on depression: Results of the ENCODE randomized controlled trial // Epilepsia. Epilepsia, 2019. Vol. 60, № 4. P. 656–668. 447. Tang V., Michaelis R., Kwan P. Psychobehavioral therapy for epilepsy // Epilepsy Behav. Epilepsy Behav, 2014. Vol. 32. P. 147–155. 448. Caller T.A. et al. A cognitive behavioral intervention (HOBSCOTCH) improves quality of life and attention in epilepsy // Epilepsy Behav. Epilepsy Behav, 2016. Vol. 57, № Pt A. P. 111–117. 449. Казенных Т.В., Бохан Н.А. Роль психотерапевтической коррекции при проведении комплексной терапии у больных пароксизмальными состояниями различного генеза // Международный журнал прикладных и фундаментальных исследований. Общество с ограниченной ответственностью" Издательский Дом" Академия …, 2016. № 6–3. P. 470–476. 239 450. Kertesz-BriestH.A. etal. Examining relations between neuropsychological and clinical epilepsy-specific factors with psychopathology and adaptive skills outcomes in youth with intractable epilepsy // Epilepsy Behav. EpilepsyBehav, 2020. Vol. 110. 451. Приказ Министерства здравоохранения Российской Федерации от 28 сентября 2020 г. N 1029н «Об утверждении перечней медицинских показаний и противопоказаний для санаторно-курортного лечения» http://publication.pravo.gov.ru/Document/View/0001202010270044. 452. WHO, ILAE, IBE. Epilepsy. A public health imperative. Geneva, 2019. xiii–xiii p. 453. The Lancet. Epilepsy prevention: an urgent global unmet need // Lancet. Lancet Publishing Group, 2019. Vol. 393, № 10191. P. 2564. 454. Приказ Министерства здравоохранения Российской Федерации от 24 декабря 2012 г. № 1404н “Об утверждении стандарта первичной медико-санитарной помощи при парциальной эпилепсии (фаза диагностики и подбора терапии)” [Electronicresource]. URL: https://minzdrav.gov.ru/documents/8345-prikaz-ministerstva-zdravoohraneniya-rossiyskoy- federatsii-ot-24-dekabrya-2012-g-1404n-ob-utverzhdenii-standarta-pervichnoy-mediko- sanitarnoy-pomoschi-pri-partsialnoy-epilepsii-faza-diagnostiki-i-podbora-terapii (accessed: 30.05.2021). 455. Приказ Министерства здравоохранения Российской Федерации от 24 декабря 2012 г. № 1439н “Об утверждении стандарта первичной медико-санитарной помощи при генерализованной эпилепсии” [Electronicresource]. URL: https://minzdrav.gov.ru/documents/8348-prikaz-ministerstva-zdravoohraneniya-rossiyskoy- federatsii-ot-24-dekabrya-2012-g-1439n-ob-utverzhdenii-standarta-pervichnoy-mediko- sanitarnoy-pomoschi-pri-generalizovannoy-epilepsii (accessed: 30.05.2021). 456. Приказ Министерства здравоохранения Российской Федерации от 24 декабря 2012 г.№ 1541н “Об утверждении стандарта специализированной медицинской помощи при эпилепсии” [Electronicresource]. URL: https://minzdrav.gov.ru/documents/8941- prikaz-ministerstva-zdravoohraneniya-rossiyskoy-federatsii-ot-24-dekabrya-2012-g-1541n-ob- utverzhdenii-standarta-spetsializirovannoy-meditsinskoy-pomoschi-pri-epilepsii. 457. Приказ Министерства здравоохранения Российской Федерации от 05.07.2016 № 468н “Об утверждении стандарта скорой медицинской помощи при судорогах, эпилепсии, эпилептическом статусе” [Electronicresource]. URL: http://publication.pravo.gov.ru/Document/View/0001201607180038. 458. Приказ Минздрава России от 10.12.2013 № 916н «О перечне видов высокотехнологичной медицинской помощи» [Electronicresource]. URL: https://minjust.consultant.ru/documents/8516. 240 459. Labiner D.M. et al. Essential services, personnel, and facilities in specialized epilepsy centers-Revised 2010 guidelines // Epilepsia. Epilepsia, 2010. Vol. 51, № 11. P. 2322– 2333. 460. Benbadis S.R., Differential diagnosis of epilepsy: acritical review. Epilepsy Behav 15: 2009: 15–21 461. Wiglusz M.S., Landowski J, Michalak L, Cubała WJ. Validation of the Hospital Anxiety and Depression Scale in patients with epilepsy. Epilepsy Behav. 2016 May;58:97-101. doi: 10.1016/j.yebeh.2016.03.003. Epub 2016 Apr 9. PMID: 27064829. 462. Котов А.С. Сбор анамнеза и осмотр у пациентов с эпилепсией. Клиническая лекция / А.С. Котов, К.В. Фирсов // Русский медицинский журнал. Медицинское обозрение. – 2019. – Т. 3. – № 7. – С. 4-7. 463. Наумова Г. И. Организация медицинской помощи пациентам с впервые развившимся судорожным припадком // Неврология, нейропсихиатрия, психосоматика. 2009 (2): С. 37-41. 464. Yeshokumar AK, Coughlin A, Fastman J, Psaila K, Harmon M, Randell T, Schorr EM, Han H, Hoang H, Soudant C, Jette N. Seizures in autoimmune encephalitis-A systematic review and quantitative synthesis. Epilepsia. 2021 Feb;62(2):397-407. 465. Кочеткова О. Н. Нейроцистицеркоз: особенности клинико- патоморфологической картины, судорожного синдрома, современные методы диагностики и лечения / О.Н. Кочеткова, А.И. Кочетков // Вестник Воронежского государственного университета. Серия: Химия. Биология. Фармация. – 2013. – № 2. – С. 110-115. 466. Еремин, А.О. Клинические особенности эпилепсии у пациентов с ВИЧ- инфекцией / А.О. Еремин, И.Н. Тихомирова // Вестник Совета молодых учёных и специалистов Челябинской области. – 2016. – Т. 5. – № 4(15). – С. 27-29. 467. Фомина М.Ю., Щербук Ю.А., Воронин Е.Е., Рахманова А.Г. Особенности поражения нервной системы при перинатальной и парентеральной ВИЧ-инфекции / // Медико-биологические и социально-психологические проблемы безопасности в чрезвычайных ситуациях. – 2009. – № 2. – С. 55-61. 468. Krumholz A. et al. Evidence-based guideline: Management of an unprovoked first seizure in adults // Neurology. Lippincott Williams and Wilkins, 2015. Vol. 84, № 16. P. 1705– 1713. 469. Koutroumanidis M. et al. The role of EEG in the diagnosis and classification of the epilepsy syndromes: a tool for clinical practice by the ILAE Neurophysiology Task Force (Part 2). EpilepticDisord. 2017 Dec 1;19(4):385-437. doi: 10.1684/epd.2017.0952. PMID: 29350182. 241 470. Перепелова Е.М, Перепелов В.А, Меркулова М.С, Синицын В.Е. Современные подходы к диагностике с помощью магнитно-резонансной томографии эпилептогенных и сопряженных с ними поражений головного мозга. Неврология, нейропсихиатрия, психосоматика. 2018;(спецвыпуск 1):4-11. 471. Wolf NI, Bast T, Surtees R. Epilepsy in inborn errors of metabolism. Epileptic Disord. 2005 Jun;7(2):67-81. 472. Tomson T, Battino D, Bromley R, Kochen S, Meador K, Pennell P, Thomas SV. Management of epilepsy in pregnancy: a report from the International League Against Epilepsy Task Force on Women and Pregnancy. Epileptic Disord. 2019 Dec 1;21(6):497-517. 473. French J.A. et al. Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study // Lancet. Lancet Publishing Group, 2016. Vol. 388, № 10056. P. 2153–2163. 474. Muthaffar OY. Neurosciences (Riyadh) Treating epilepsy with options otherthan antiepileptic medications. 2020 Aug;25(4):253-261. doi: 10.17712/nsj.2020.4.20200010. 475. Клинические рекомендации по диагностике и лечению эпилепсии. В кн. Детская неврология. Клинические рекомендации. Выпуск1. Под редакцией В.И. Гузевой – Москва: ООО «МК»: 2014; стр.316-317. 476 Белоусова, Е. Д. Гормональная терапия синдрома Веста / Е. Д. Белоусова, И. В. Шулякова, Т. Г. Охапкина // Журнал неврологии и психиатрии им. C.C. Корсакова. – 2016. – Т. 116. – № 9-2. – С. 61-66. – DOI 10.17116/jnevro20161169261-66 477. Haberlandt E, Weger C, Baumgartner Sigl S, et al. Adrenocorticotropic hormone versus pulsatile dexamethasone in the treatment of infantile epilepsy syndromes. Pediatr Neurol. 2010;42:21–7. 478. К.Ю. Мухин, А.С. Петрухин. Эпилептические синдромы. Диагностика и стандарты терапии (Справочное руководство), М.; 2005; стр.75. 479. Chiron C, Dumas C, Jambaqué I, Mumford J, Dulac O. Randomized trial comparing vigabatrin and hydrocortisone in infantile spasms due to tuberous sclerosis. Epilepsy Res. 1997 Jan; 26 (2): 389-95. doi: 10.1016/s0920-1211(96)01006-6. PMID: 9095401. 480. Silbergleit R., Durkalski V., Lowenstein D., Conwit R., Pancioli A., Palesch Y., Barsan W. for the NETT Investigators. Intramuscular versus Intravenous Therapy for Prehospital Status Epilepticus. N Engl J Med 2012; 366: 591-600 DOI: 10.1056/NEJMoa1107494. 481. Berg A.T., Testa F.M., Levy S.R. Complete remission in nonsyndromic childhood- onset epilepsy // Ann. Neurol. Ann Neurol, 2011. Vol. 70, № 4. P. 566–573. 242 482. Goellner E. et al. Timing of early and late seizure recurrence after temporal lobe epilepsy surgery // Epilepsia. Epilepsia, 2013. Vol. 54, № 11. P. 1933–1941. 483. Lindsten H., Stenlund H., Forsgren L. Remission of seizures in a population-based adult cohort with a newly diagnosed unprovoked epileptic seizure // Epilepsia. Epilepsia, 2001. Vol. 42, № 8. P. 1025–1030. 484. Blume W.T. et al. Glossary of descriptive terminology for ictal semiology: Report of the ILAE Task Force on classification and terminology // Epilepsia. Epilepsia, 2001. Vol. 42, № 9. P. 1212–1218. 485. Berg A.T. et al. Revised terminology and concepts for organization of seizures and epilepsies: Report of the ILAE Commission on Classification and Terminology, 2005-2009 // Epilepsia. Epilepsia, 2010. Vol. 51, № 4. P. 676–685. 486. Zinchuk M, Kustov G, Pashnin E, et al. Validation of the Generalized Anxiety Disorder-7 (GAD-7) in Russian people with epilepsy. |